Shanghai Xuerong Biotechnology Co., Ltd. (SHE:300511)
China flag China · Delayed Price · Currency is CNY
5.15
+0.11 (2.18%)
At close: Jul 31, 2026

SHE:300511 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
297.51161.45167.95252.67363.82340.77
Short-Term Investments
---0.06--
Trading Asset Securities
----270-
Cash & Short-Term Investments
297.51161.45167.95252.72633.82340.77
Cash Growth
564.38%-3.87%-33.54%-60.13%86.00%-55.16%
Accounts Receivable
46.0843.7731.3933.4829.0228.86
Other Receivables
5.788.65.556.2850.1318.89
Receivables
51.8752.3736.9539.7679.1547.74
Inventory
399.99371.68325.34442.86443.28384.08
Prepaid Expenses
-3.982.95.743.972.11
Other Current Assets
24.8916.5613.1725.5132.34100.24
Total Current Assets
774.26606.04546.31766.61,193874.94
Property, Plant & Equipment
2,5992,6642,9653,4602,5792,945
Long-Term Investments
12.0512.0515.616.2421.4632.61
Other Intangible Assets
296.19299.43299.63306.9221.72328.38
Long-Term Deferred Tax Assets
-----12.83
Long-Term Deferred Charges
5.646.147.9121.8126.4847.77
Other Long-Term Assets
21.214.0919.8730.6830.8295.96
Total Assets
3,7093,6013,8554,6024,0724,337

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
259.58320.95298.35318.15215.87214.13
Accrued Expenses
44.7460.5278.0766.9261.8455.59
Short-Term Debt
366.9926.15985.851,036575.76777.49
Current Portion of Long-Term Debt
-114.07146.19168.69170.4248.23
Current Portion of Leases
-1.151.054.011.131.07
Current Income Taxes Payable
4.870---0.01
Current Unearned Revenue
10.826.4720.627.1616.2314.15
Other Current Liabilities
490.15327.48418.11512.47256.29295.98
Total Current Liabilities
1,1771,7571,9482,1131,2981,607
Long-Term Debt
739.7219.98960.21948.27973.69954.69
Long-Term Leases
16.6528.9554.2924.4123.4523.45
Long-Term Unearned Revenue
56.457.1960.5651.1243.8949.68
Other Long-Term Liabilities
30.8924.967.9433.08107.6451.12
Total Liabilities
2,0212,0883,0313,1702,4462,686

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
640.85640.85498.82498.78503.04441.92
Additional Paid-In Capital
1,3141,314741.98741.82753.99471.77
Retained Earnings
-165.01-338.18-367.98249.09437.16724.38
Treasury Stock
-----16.43-34.7
Comprehensive Income & Other
-6-4.765.8164.8365.5165.98
Total Common Equity
1,7841,612938.631,5551,7431,669
Minority Interest
-95.91-98.53-115.31-122.15-117.43-17.5
Shareholders' Equity
1,6881,513823.321,4321,6261,652
Total Liabilities & Equity
3,7093,6013,8554,6024,0724,337

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,1231,2902,1482,1811,7442,005
Net Cash (Debt)
-825.73-1,129-1,980-1,928-1,111-1,664
Net Cash Growth
------
Net Cash Per Share
-1.44-1.89-3.98-3.90-2.28-3.85
Filing Date Shares Outstanding
640.85640.85498.82498.78503.04507.6
Total Common Shares Outstanding
640.85640.85498.82498.78503.04441.92
Working Capital
-402.8-1,151-1,402-1,346-104.97-731.7
Book Value Per Share
2.782.521.883.123.473.78
Tangible Book Value
1,4881,313638.991,2481,5221,341
Tangible Book Value Per Share
2.322.051.282.503.023.03
Buildings
-2,3262,3162,2831,9291,922
Machinery
-2,5892,6872,5982,1872,209
Construction In Progress
-20.2853.49360.3168.28151.74